| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new invertebrate NPY-like polypeptide, ZoaNPY, from the Zoanthus sociatus, as a novel ligand of human NPY Y2 receptor rescues vascular insufficiency via PLC/PKC and Src- FAK-dependent signaling pathways
|
Chen, Qian
|
|
|
203 |
C |
p.
|
artikel
|
| 2 |
Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition
|
Cai, Yongfeng
|
|
|
203 |
C |
p.
|
artikel
|
| 3 |
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors
|
Manduca, Antonia
|
|
|
203 |
C |
p.
|
artikel
|
| 4 |
Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42
|
Kücük, Pelin
|
|
|
203 |
C |
p.
|
artikel
|
| 5 |
Cisplatin-based combination therapies: Their efficacy with a focus on ginsenosides co-administration
|
Li, Keke
|
|
|
203 |
C |
p.
|
artikel
|
| 6 |
Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas
|
Roskoski Jr., Robert
|
|
|
203 |
C |
p.
|
artikel
|
| 7 |
Corrigendum to “Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis” [Pharmacol. Res. 173 (2021) 105882]
|
Khuanjing, Thawatchai
|
|
|
203 |
C |
p.
|
artikel
|
| 8 |
Corrigendum to “ACOX1 deficiency-induced lipid metabolic disorder facilitates chronic interstitial fibrosis development in renal allografts” [Pharmacol. Res. 201 (2024) 107105]
|
Zhang, Yang-He
|
|
|
203 |
C |
p.
|
artikel
|
| 9 |
Depletion of regulatory T cells enhancing the anti-tumor effect of in situ vaccination in solid tumors
|
Xie, Ya-Jia
|
|
|
203 |
C |
p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
203 |
C |
p.
|
artikel
|
| 11 |
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review
|
Barbieri, Michelangela
|
|
|
203 |
C |
p.
|
artikel
|
| 12 |
Encapsulated cell technology: Delivering cytokines to treat posterior ocular diseases
|
Wang, Jiale
|
|
|
203 |
C |
p.
|
artikel
|
| 13 |
ER-organelle contacts: A signaling hub for neurological diseases
|
Wang, Yunli
|
|
|
203 |
C |
p.
|
artikel
|
| 14 |
Hydrogen sulfide supplementation as a potential treatment for primary mitochondrial diseases
|
Slade, Luke
|
|
|
203 |
C |
p.
|
artikel
|
| 15 |
IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation
|
Zhu, Jingyan
|
|
|
203 |
C |
p.
|
artikel
|
| 16 |
IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment
|
Chowdhury, Iftekhar Hossain
|
|
|
203 |
C |
p.
|
artikel
|
| 17 |
Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects
|
Zhu, Yuankui
|
|
|
203 |
C |
p.
|
artikel
|
| 18 |
Metabolic regulation of the Th17/Treg balance in inflammatory bowel disease
|
Zhang, Shunfen
|
|
|
203 |
C |
p.
|
artikel
|
| 19 |
Mitofilin in cardiovascular diseases: Insights into the pathogenesis and potential pharmacological interventions
|
Chaurembo, Abdallah Iddy
|
|
|
203 |
C |
p.
|
artikel
|
| 20 |
Molecular insight into T cell exhaustion in hepatocellular carcinoma
|
Zhu, Yonghua
|
|
|
203 |
C |
p.
|
artikel
|
| 21 |
Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
|
Kumar, Aviral
|
|
|
203 |
C |
p.
|
artikel
|
| 22 |
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
|
Wang, Zhonglei
|
|
|
203 |
C |
p.
|
artikel
|
| 23 |
PCSK9 inhibition and broad health outcomes: A Mendelian randomization phenome‑wide association study
|
Zhang, Kai
|
|
|
203 |
C |
p.
|
artikel
|
| 24 |
Perivascular fat tissue and vascular aging: A sword and a shield
|
Wang, Yan
|
|
|
203 |
C |
p.
|
artikel
|
| 25 |
Pharmacological agents targeting drug-tolerant persister cells in cancer
|
Chen, Yu-Chi
|
|
|
203 |
C |
p.
|
artikel
|
| 26 |
Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions
|
Pinazo-Bandera, J.M.
|
|
|
203 |
C |
p.
|
artikel
|
| 27 |
Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer’s disease
|
Pierson, Samantha R.
|
|
|
203 |
C |
p.
|
artikel
|
| 28 |
Serotonin regulation of mitochondria in kidney diseases
|
Hurtado, Kevin
|
|
|
203 |
C |
p.
|
artikel
|
| 29 |
SIRT1: Harnessing multiple pathways to hinder NAFLD
|
Tian, Cheng
|
|
|
203 |
C |
p.
|
artikel
|
| 30 |
Targeting AQP9 enhanced the anti-TNF therapy response in Crohn's disease by inhibiting LPA-hippo pathway
|
Yu, Minhao
|
|
|
203 |
C |
p.
|
artikel
|
| 31 |
Targeting epigenetic and post-translational modifications regulating pyroptosis for the treatment of inflammatory diseases
|
Ri-Wen,
|
|
|
203 |
C |
p.
|
artikel
|
| 32 |
The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk
|
Xu, Chang
|
|
|
203 |
C |
p.
|
artikel
|
| 33 |
The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives
|
Wei, Xuejiao
|
|
|
203 |
C |
p.
|
artikel
|
| 34 |
The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer
|
Wang, Youzhi
|
|
|
203 |
C |
p.
|
artikel
|
| 35 |
The major histocompatibility complex participates in Parkinson’s disease
|
Gu, Rou
|
|
|
203 |
C |
p.
|
artikel
|
| 36 |
The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs
|
Hadiloo, Kaveh
|
|
|
203 |
C |
p.
|
artikel
|
| 37 |
The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis
|
Lin, Chu
|
|
|
203 |
C |
p.
|
artikel
|
| 38 |
Therapeutic stapled peptides: Efficacy and molecular targets
|
Li, Yulei
|
|
|
203 |
C |
p.
|
artikel
|
| 39 |
Treating cancer through modulating exosomal protein loading and function: The prospects of natural products and traditional Chinese medicine
|
Meng, Lulu
|
|
|
203 |
C |
p.
|
artikel
|
| 40 |
Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy
|
Zhang, Jinjing
|
|
|
203 |
C |
p.
|
artikel
|
| 41 |
Validation of collection and anaerobic fermentation techniques for measuring prebiotic impact on gut microbiota
|
Thorman, Alexander W.
|
|
|
203 |
C |
p.
|
artikel
|
| 42 |
When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?
|
Fu, Chen
|
|
|
203 |
C |
p.
|
artikel
|
Tijdschrift beschrijving